Fresenius Medical Care AG (FMCQF) Liabilities and Shareholders Equity (2009 - 2023)

Fresenius Medical Care AG (FMCQF) has reported Liabilities and Shareholders Equity for 17 consecutive years, with $36.1 billion the latest figure, recorded in Q4 2025.

• In Q4 2025, Liabilities and Shareholders Equity rose 0.61% year-over-year to $36.1 billion; the TTM figure through Dec 2025 stood at $142.0 billion (down 2.29% YoY), while the FY2025 annual figure was $36.1 billion, up 0.61% from the prior year.
• Liabilities and Shareholders Equity came in at $36.1 billion for Q4 2025 at Fresenius Medical Care AG, roughly flat from $36.1 billion in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $40.0 billion in Q1 2021, with the low at $43.7 million in Q4 2022.
• Average Liabilities and Shareholders Equity over 5 years is $33.7 billion, with a median of $36.9 billion recorded in 2023.
• Across the five-year window, Liabilities and Shareholders Equity plunged 74.21% in 2021 and jumped 83516.35% in 2023, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $58.0 million in 2021, then decreased by 24.69% to $43.7 million in 2022, then surged by 83516.35% to $36.5 billion in 2023, then retreated by 1.74% to $35.9 billion in 2024, then climbed by 0.61% to $36.1 billion in 2025.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $36.1 billion, $36.1 billion, and $35.4 billion for Q4 2025, Q3 2025, and Q2 2025 respectively.